Properdistatin

General Information


DRACP ID  DRACP04881

Peptide Name   Properdistatin

Sequence  GPWEPCSVTCSKGTRTRRR

Sequence Length  19

UniProt ID  Not available

PubChem CID  Not available

Origin  Homo sapiens (Properdin)

Type  Synthetic peptide

Classification

  

Active ACP Cancer targeted peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  CD36

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C89H149N33O27S2

Absent amino acids  ADFHILMNQY

Common amino acids  R

Mass  249870

Pl  11.31

Basic residues  5

Acidic residues  1

Hydrophobic residues  2

Net charge  4

Boman Index  -7574

Hydrophobicity  -130.53

Aliphatic Index  15.26

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5625

Absorbance 280nm  312.5

Polar residues  9

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18780781

Title  A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells

Doi 10.1073/pnas.0803241105

Year  2008

Literature 2

Pubmed ID 21470139

Title  Anti-angiogenic peptides for cancer therapeutics

Doi 10.2174/138920111796117300

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.